Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children’s Oncology Group Study AALL03N1
Wendy Landier(University of Alabama at Birmingham), Ravi Bhatia(University of Alabama at Birmingham), Lindsey Hageman(Tianjin Chengjian University), Mary V. Relling(St. Jude Children's Research Hospital), F. Lennie Wong(Tianjin Chengjian University), Anne Angiolillo(Children's National), William E. Evans(St. Jude Children's Research Hospital), A. Kim Ritchey(Children's Hospital of Pittsburgh), Jacqueline Casillas(University of California, Los Angeles), Yan-Jun Chen(Hunan University of Traditional Chinese Medicine), David S. Dickens(Albert Einstein College of Medicine), Leo Mascarenhas(University of Southern California), Kelly W. Maloney(Children's Hospital Colorado), William L. Carroll(NYU Langone Health), Nancy Kornegay(Tianjin Chengjian University), Bruce Bostrom(Minnesota West Community & Technical College), Glen Lew(Emory University), Amanda Termuhlen
Cited by 41
Related Papers
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
|Cancer Cell|2002|1.9k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k